What are the complications of the Soave and Swenson pull-through procedures for Hirschsprung disease?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 30, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Complications of Soave and Swenson Procedures for Hirschsprung Disease

Both the Soave and Swenson pull-through procedures carry distinct complication profiles: Soave is associated with anastomotic stricture (requiring reoperation in 5.5% of cases due to retained aganglionic muscular cuff) and higher rates of postoperative constipation, while Swenson carries a higher risk of anastomotic leakage (particularly in adults) and potential pelvic nerve injury, though it demonstrates superior bowel function scores and lower constipation rates at intermediate follow-up 1, 2, 3.

Early Postoperative Complications (≤30 days)

Common to Both Procedures

Hirschsprung-associated enterocolitis (HAEC) remains the most frequent early complication, occurring in approximately 14.5-20% of cases regardless of technique 1. The overall early complication rate following laparoscopic-assisted procedures is approximately 17%, with most complications classified as Clavien-Dindo Grade II (50%), requiring medical management only 4.

Additional early complications include:

  • Perianal skin erosion (9.1%)
  • Abdominal wound infection (4.6%)
  • Adhesive bowel obstruction (13.6%)
  • Anastomotic complications (see procedure-specific details below)
  • Rare but serious: Small bowel volvulus (case reports of 720° rotation requiring emergency laparotomy) 5

Procedure-Specific Early Complications

Soave Procedure:

  • Anastomotic stricture requiring reoperation: 5.5% (3/55 patients) 1
  • Rectal retraction: 4.5% 4
  • Cuff-related obstruction from retained aganglionic muscular tissue 1

Swenson Procedure:

  • Anastomotic leakage: Higher risk, particularly in adults (2/5 cases in one series) 3
  • Peritonitis from anastomotic dehiscence 6
  • Urethral injury during peri-rectal dissection (requires secondary repair) 6
  • Pneumoperitoneum requiring relaparotomy 6

Critical Risk Factors for Early Complications

Independent predictors requiring preoperative optimization 4:

  • Preoperative hypoalbuminemia (OR=9.14; 95% CI: 2.68-30.97) - strongest predictor
  • Preoperative stoma (OR=4.83; 95% CI: 1.19-20.16)
  • Preoperative anemia (univariate significance)

Operative Considerations

Swenson demonstrates superior operative efficiency 2:

  • 26 minutes shorter operative time (MD: 26.39 min; 95% CI: 11.32-41.46)
  • 15.5 mL less intraoperative blood loss (MD: 15.53 mL; 95% CI: 13.83-17.24)
  • 1.5 days shorter hospital stay (MD: 1.50 days; 95% CI: 0.27-2.72)

However, adult procedures using either technique typically exceed 300 minutes and require 300-800 mL blood/plasma transfusion 3.

Long-Term Functional Outcomes

Bowel Function

Swenson provides modestly superior bowel function at 2-year follow-up 1:

  • Rintala Bowel Function Score: 18.20±1.80 (Swenson) vs. 17.10±2.30 (Soave), p=0.037
  • Postoperative constipation: Significantly less frequent after Swenson (OR=2.20; 95% CI: 1.04-4.64) 2

The clinical significance is limited (1.1-point difference), and quality of life scores remain comparable between techniques (PedsQL: 88.6±7.5 vs. 86.2±8.4, p=0.12) 1.

Continence Issues

Approximately 32.5% of patients develop fecal incontinence/soiling postoperatively, though 68% achieve social continence with targeted multidisciplinary rehabilitation 7. Obstructive symptoms occur in 19.8% initially but decrease by >75% with appropriate management 7.

Technical Pitfalls and Prevention Strategies

Critical Technical Steps Where Complications Arise 6:

  1. Aganglionic level evaluation: Inadequate frozen section assessment leads to retained aganglionic tissue
  2. Peri-rectal dissection:
    • Mandatory urethral stent placement to prevent urethral injury
    • Precise dissection technique to avoid pelvic nerve damage (higher risk with Swenson)
  3. Anastomosis creation: Careful technique prevents leakage and stricture

Specific Recommendations:

  • For Swenson in adults: Protective colostomy is recommended due to high anastomotic leakage risk 3
  • Transanal approach: Only 63% achieve truly scarless outcomes; requires meticulous technique 6
  • Preoperative optimization: Correct hypoalbuminemia and anemia before elective surgery 4

Long-Term Follow-Up Requirements

Structured multidisciplinary surveillance is mandatory 8:

  • Nutritional monitoring: Individualized dietary guidance
  • Anastomotic calibration: Postoperative assessment for stricture
  • HAEC surveillance: Ongoing risk throughout childhood
  • Sexual and fertility health: Assessment during adolescence/adulthood
  • Transition to adult care: Structured handoff protocol
  • Renal screening: Preoperative evaluation for associated anomalies

Routine preventive anal dilatations are no longer recommended 8.

Clinical Decision Algorithm

Choose Swenson when:

  • Prioritizing lower constipation risk
  • Shorter operative time is advantageous
  • Surgeon experienced in precise pelvic dissection
  • Use protective colostomy in adults

Choose Soave when:

  • Minimizing pelvic nerve injury risk is paramount
  • Surgeon less experienced with deep pelvic dissection
  • Accept 5.5% reoperation risk for cuff-related stricture

Both techniques require:

  • Preoperative correction of hypoalbuminemia (albumin >3.5 g/dL target)
  • Correction of anemia
  • Urethral stent during dissection
  • Experienced surgeon (>300 min operative time expected)
  • Lifelong multidisciplinary follow-up

The limited clinical magnitude of functional differences (1.1 Rintala points) means surgeon expertise and institutional experience should guide technique selection rather than dogmatic preference 1.

References

Research

Laparoscopic-Assisted Swenson-Like versus Soave Pull-Through in Hirschsprung Disease: A Randomized Comparative Study of Functional Outcomes.

European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie, 2026

Research

Adult Hirschsprung's disease in Jamaica: operative treatment and outcome.

Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland, 2011

Research

Technical problems and complications of a transanal pull-through for Hirschsprung's disease.

European journal of pediatric surgery : official journal of Austrian Association of Pediatric Surgery ... [et al] = Zeitschrift fur Kinderchirurgie, 2006

Related Questions

In a child with Hirschsprung disease, how do the Soave and Swensen pull‑through procedures compare regarding technique, risks, and postoperative outcomes?
What are the indications for creating a protective colostomy during a pull‑through procedure for Hirschsprung disease?
In a stable infant with rectosigmoid Hirschsprung disease, why is a protective colostomy not indicated?
In a patient with abdominal distension, vomiting, and constipation, how can I differentiate Hirschsprung disease from intestinal volvulus and what are the initial management steps for each?
What are the inheritance patterns and de novo inheritance rates of Hirschsprung disease, and is there any association between maternal drug use and Hirschsprung-like disease in the fetus?
What is the likely diagnosis and recommended workup and treatment for a finding of greater trochanter cortical irregularity with a hypoechoic soft‑tissue area?
What is the appropriate management for a patient who intermittently stops and restarts antipsychotic medication and now presents with muscle aches, low‑grade fever, and rigidity?
What are the indications for ordering the tumor markers CA-125 (cancer antigen 125), CA 15-3 (cancer antigen 15-3), and CEA (carcinoembryonic antigen)?
What is the appropriate evaluation and treatment for septic knee in a diabetic female patient with rheumatoid arthritis?
How should a 9-year-old child with diffuse body aches and normal laboratory studies, including normal creatine kinase, be evaluated and managed?
Are any of these tumor markers (CA‑125, CA‑15‑3, carcinoembryonic antigen) indicated for screening asymptomatic individuals?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.